IFNγ inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21(WAF1/CIP1)

Oncogene

Volumn 17, Issue 23, 1998, Pages 2973-2979

  Kominsky, Scott ^a   Johnson, Howard M ^a   Bryan, Gail ^a   Tanabe, Taishi ^a   Hobeika, Amy C ^a   Subramaniam, Prem S ^a   Torres, Barbara ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cyclin dependent kinase 2; Glioblastoma; Interferon ; p21(WAF1 CIP1)

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; GAMMA INTERFERON; PROTEIN P21; CDK2 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; GROWTH INHIBITOR; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; METABOLISM;

CDC2-CDC28 KINASES; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; GLIOBLASTOMA; GROWTH INHIBITORS; HUMANS; INTERFERON TYPE II; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 0032506347     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202217     Document Type: Article

References (13)

1. Cayrol C, Knibiehler M and Ducommun B. (1998). Oncogene, 16, 311-320.
2. Chin YE, Kitagawa M, Su W-C, You Z-H, Iwamoto Y and Fu X-Y. (1996). Science, 272, 719-722.
3. Greenblatt MS, Bennett WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4862.
4. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai L, Zhang P, Dobtowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. (1995). Mol. Biol. Cell., 6, 387-400.
5. Hobeika AC, Subramaniam PS and Johnson HM. (1997). Oncogene, 14, 1165-1170.
6. Jiang H, Lin J, Su Z, Collart F, Huberman E and Fisher P. (1994). Oncogene, 9, 3397-3406.
7. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, and Craig RW. (1991). Cancer Res., 51, 6304-6311.
8. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, and Burger PC. (1995). Glia, 15, 211-221.
9. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Peterson I, Holl T, Weistler OD, and Kleihues P. (1993). Mol. Carcinog., 8, 74-80.
10. Parker S, Eichele G, Zhang P, Rawls A, Sands A, Bradley A, Olson E, Harper J, and Elledge S. (1995). Science, 267, 1024-1027.
11. Subramaniam PS, and Johnson HM. (1997). J. Interferon Cytokine Res., 17, 11-15.
12. Waga S, Hannon G, Beach D, and Stillman B. (1994). Nature, 369, 574-578.
13. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, and Beach D. (1993). Nature, 366, 701-704.